CYP2A6 and lung carcinoma: Of particular interests are studies on smoking behavior and genes that code for those drug-metabolizing enzymes and gene-environmental interactions as well as studies on lung cancer and metabolic polymorphisms.106 As shown in Table 1, data regarding correlations between smoking prevalence and polymorphisms in CYP2A6 and CYP2D6 enzymes are limited.